This brief case describes Daiichi Kangyo's purchase of a majority shareholding in Ranbaxy in 2008, along with resolutions Indian drug maker Ranbaxy has made with Pfizer and AstraZeneca.
Recent Developments in the Ranbaxy Case Case Study Solution
PUBLICATION DATE: July 02, 2008 PRODUCT #: 609010-HCB-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Genetic Testing and the Puzzles We Are Left To Solve (K)
Genetic Testing and the Puzzles We Are Left To Solve (F)
Martin Marietta: Managing Corporate Ethics (C1)
Snehalaya
Leading Innovation at Kelvingrove (B)
We Have a Terrible Tragedy Here (B)
When a Pandemic Hits: Treading H2O and the Possible Pox (B)
Crafting And Executing An Offshore IT Sourcing Strategy: GlobShop’s Experience
Cumberland Entertainment (A): Expanding with Private Equity? Award winner Prize Winner
Nuru Energy (A): Financing a Social Enterprise Award winner Prize Winner
